{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:47:07Z","timestamp":1782107227836,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,21]]},"DOI":"10.7759\/cureus.111261","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:53:33Z","timestamp":1782104013000},"source":"Crossref","is-referenced-by-count":0,"title":["Antihypertensive Regimens in Stabilized Hypertensive Patients at a Malagasy Tertiary Hospital"],"prefix":"10.7759","author":[{"given":"Rado Olivier","family":"Rakoto Sedson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holy Mihanta Sabrina","family":"Ranaivoson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rija Mikhael","family":"Miandrisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamisoa Herinirina","family":"Nomenjanahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Os\u00e9 Judica\u00ebl","family":"Harioly Nirina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solofonirina","family":"Rakotoarimanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirina","family":"Rabearivony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills KT","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020, 16:223-37. 10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104300","article-title":"Estimating the prevalence and awareness rates of hypertension in Africa: A systematic analysis","volume":"9","author":"Adeloye D","year":"2014","unstructured":"Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: A systematic analysis. PLoS One. 2014, 9:e104300. 10.1371\/journal.pone.0104300","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.05.007","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"86","author":"Jones DW","year":"2025","unstructured":"Jones DW, Ferdinand KC, Taler SJ, et al.. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025, 86:1567-678. 10.1016\/j.jacc.2025.05.007","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.18166","article-title":"Is a low-dose triple-drug combination pill protocol the answer for hypertension control in Sub-Saharan Africa?","volume":"332","author":"Mensah GA","year":"2024","unstructured":"Mensah GA. Is a low-dose triple-drug combination pill protocol the answer for hypertension control in Sub-Saharan Africa?. JAMA. 2024, 332:1057-8. 10.1001\/jama.2024.18166","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"31","author":"ESH\/ESC Task Force for the Management of Arterial Hypertension","year":"2013","unstructured":"ESH\/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013, 31:1925-38. 10.1097\/HJH.0b013e328364ca4c","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049632","article-title":"Blood pressure-lowering medicines implemented in 12 African countries: The cross-sectional multination EIGHT study","volume":"11","author":"Cavagna P","year":"2021","unstructured":"Cavagna P, Takombe JL, Damorou JM, et al.. Blood pressure-lowering medicines implemented in 12 African countries: The cross-sectional multination EIGHT study. BMJ Open. 2021, 11:e049632. 10.1136\/bmjopen-2021-049632","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2022-065","article-title":"Hypertension treatment in sub-Saharan Africa: A systematic review","volume":"34","author":"Cavagna P","year":"2023","unstructured":"Cavagna P, Leplay C, N'Guetta R, et al.. Hypertension treatment in sub-Saharan Africa: A systematic review. Cardiovasc J Afr. 2023, 34:307-17. 10.5830\/CVJA-2022-065","journal-title":"Cardiovasc J Afr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/651634","article-title":"Management of hypertension in the elderly patient at Abidjan Cardiology Institute (Ivory Coast)","volume":"2012","author":"Kramoh KE","year":"2012","unstructured":"Kramoh KE, Ak\u00e9-Traboulsi E, Konin C, et al.. Management of hypertension in the elderly patient at Abidjan Cardiology Institute (Ivory Coast). Int J Hypertens. 2012, 2012:651634. 10.1155\/2012\/651634","journal-title":"Int J Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-024-00358-5","article-title":"Single-pill, triple antihypertensive therapy in rural Sub-Saharan Africa: Preliminary experience","volume":"13","author":"Stroppa C","year":"2024","unstructured":"Stroppa C, Hunjan I, Umulisa A, et al.. Single-pill, triple antihypertensive therapy in rural Sub-Saharan Africa: Preliminary experience. Cardiol Ther. 2024, 13:431-42. 10.1007\/s40119-024-00358-5","journal-title":"Cardiol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02134-0","article-title":"Use of perindopril arginine\/indapamide\/amlodipine in the management of hypertension in two Sub-Saharan African island countries of Madagascar and Mauritius","volume":"39","author":"Mbanya A","year":"2022","unstructured":"Mbanya A, Ackbarkhan A, Mittoo MY, et al.. Use of perindopril arginine\/indapamide\/amlodipine in the management of hypertension in two Sub-Saharan African island countries of Madagascar and Mauritius. Adv Ther. 2022, 39:2850-61. 10.1007\/s12325-022-02134-0","journal-title":"Adv Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3877","article-title":"Analysis of dual combination therapies used in treatment of hypertension in a multinational cohort","volume":"5","author":"Lu Y","year":"2022","unstructured":"Lu Y, Van Zandt M, Liu Y, et al.. Analysis of dual combination therapies used in treatment of hypertension in a multinational cohort. JAMA Netw Open. 2022, 5:e223877. 10.1001\/jamanetworkopen.2022.3877","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34965","article-title":"Blood pressure control and prescription pattern of antihypertensive drugs in adherence to the 2020 International Society of Hypertension (ISH) global hypertension practice guidelines in Saudi Arabia: A retrospective study","volume":"15","author":"Rashikh MA","year":"2023","unstructured":"Rashikh MA, Alruways AF, Alotaibi HB, Alotaibi NA, Almarshad F, Alsaab SM, Alotaibi G. Blood pressure control and prescription pattern of antihypertensive drugs in adherence to the 2020 International Society of Hypertension (ISH) global hypertension practice guidelines in Saudi Arabia: A retrospective study. Cureus. 2023, 15:e34965. 10.7759\/cureus.34965","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.48139","article-title":"Impact of patient knowledge on hypertension treatment adherence and efficacy: A single-centre study in Poland","volume":"18","author":"Paczkowska A","year":"2021","unstructured":"Paczkowska A, Hoffmann K, Kus K, et al.. Impact of patient knowledge on hypertension treatment adherence and efficacy: A single-centre study in Poland. Int J Med Sci. 2021, 18:852-60. 10.7150\/ijms.48139","journal-title":"Int J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s11522","article-title":"Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients","volume":"6","author":"Destro M","year":"2010","unstructured":"Destro M, Crikelair N, Yen J, Glazer R. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients. Vasc Health Risk Manag. 2010, 6:821-7. 10.2147\/vhrm.s11522","journal-title":"Vasc Health Risk Manag"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s6561","article-title":"Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure","volume":"4","author":"Dom\u00e9nech M","year":"2010","unstructured":"Dom\u00e9nech M, Coca A. Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure. Patient Prefer Adherence. 2010, 4:105-13. 10.2147\/ppa.s6561","journal-title":"Patient Prefer Adherence"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.37962\/jpps.v7i4.320","article-title":"Utilization study of antihypertensive medicines among insured patients at a public tertiary healthcare facility in Nigeria","volume":"7","author":"Okoro RN","year":"2019","unstructured":"Okoro RN, Nmeka C, Erah PO. Utilization study of antihypertensive medicines among insured patients at a public tertiary healthcare facility in Nigeria. RADS J Pharm Pharm Sci. 2019, 7:1-7. 10.37962\/jpps.v7i4.320","journal-title":"RADS J Pharm Pharm Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.17.24301397","article-title":"Comparative effectiveness of ARB and ACEi for cardiovascular outcomes and risk of angioedema among different ethnic groups in England: An analysis in the UK Clinical Practice Research Datalink with emulation of a reference trial (ONTARGET)","author":"Baptiste PJ","year":"2024","unstructured":"Baptiste PJ, Wong AY, Schultze A, et al.. Comparative effectiveness of ARB and ACEi for cardiovascular outcomes and risk of angioedema among different ethnic groups in England: An analysis in the UK Clinical Practice Research Datalink with emulation of a reference trial (ONTARGET). medRxiv. 2024, 10.1101\/2024.01.17.24301397","journal-title":"medRxiv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901113","article-title":"Comparison of dual therapies for lowering blood pressure in Black Africans","volume":"380","author":"Ojji DB","year":"2019","unstructured":"Ojji DB, Mayosi B, Francis V, et al.. Comparison of dual therapies for lowering blood pressure in Black Africans. N Engl J Med. 2019, 380:2429-39. 10.1056\/NEJMoa1901113","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002024","article-title":"The evidence on the 2018 ESC\/ESH Guidelines for the management of arterial hypertension in African ancestry patients","volume":"37","author":"Brewster LM","year":"2019","unstructured":"Brewster LM, van Montfrans GA, Seedat YK. The evidence on the 2018 ESC\/ESH Guidelines for the management of arterial hypertension in African ancestry patients. J Hypertens. 2019, 37:650-1. 10.1097\/HJH.0000000000002024","journal-title":"J Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/NJC.NJC_18_18","article-title":"Pattern and appropriateness of antihypertensive prescriptions among hospitalized hypertensives in Nigeria","volume":"16","author":"Akintunde AA","year":"2019","unstructured":"Akintunde AA, Karaye KM, Olusegun-Joseph D, Balarabe SA, Opadijo OG. Pattern and appropriateness of antihypertensive prescriptions among hospitalized hypertensives in Nigeria. Nig J Cardiol. 2019, 16:18-24. 10.4103\/NJC.NJC_18_18","journal-title":"Nig J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial","volume":"386","author":"Williams B","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, et al.. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial. Lancet. 2015, 386:2059-68. 10.1016\/S0140-6736(15)00257-3","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad D","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, et al.. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016, 387:957-67. 10.1016\/S0140-6736(15)01225-8","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2016:1:2","article-title":"Clinical diagnosis and management of resistant hypertension","volume":"11","author":"Tsioufis CP","year":"2016","unstructured":"Tsioufis CP, Kasiakogias A, Tousoulis D. Clinical diagnosis and management of resistant hypertension. Eur Cardiol. 2016, 11:12-7. 10.15420\/ecr.2016:1:2","journal-title":"Eur Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association","volume":"72","author":"Carey RM","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, et al.. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension. 2018, 72:e53-90. 10.1161\/HYP.0000000000000084","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/504207-antihypertensive-regimens-in-stabilized-hypertensive-patients-at-a-malagasy-tertiary-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:53:34Z","timestamp":1782104014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/504207-antihypertensive-regimens-in-stabilized-hypertensive-patients-at-a-malagasy-tertiary-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.111261","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}